Login / Signup

Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy.

Woldesellassie M BezabheJan RadfordBarbara C WimmerMohammed Saji SalahudeenIvan BindoffTristan LingGregory M Peterson
Published in: Expert review of clinical pharmacology (2022)
Use of warfarin or DOACs was associated with a significantly increased risk of developing osteoporosis compared with no OAC treatment.
Keyphrases
  • postmenopausal women
  • atrial fibrillation
  • venous thromboembolism
  • direct oral anticoagulants
  • bone mineral density
  • combination therapy
  • replacement therapy
  • cell therapy